Discover open access scientific publications

Search, annotate, share and cite publications

Publications by M. G. Rumi

Editorial: Real-Life Data Confirm Efficacy of Elbasvir/Grazoprevir in HCV Patients With Severe Kidney Disease

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Performance of the COBAS AMPLICOR HCV MONITOR Test, Version 2.0, an Automated Reverse Transcription-PCR Quantitative System for Hepatitis C Virus Load Determination

Journal of Clinical Microbiology
Microbiology
2000English

Related publications

The Efficacy and Safety of Elbasvir/Grazoprevir Treatment in HCV Genotype 1 Patients in Taiwan

Journal of Medical Virology
VirologyInfectious Diseases
2019English

Pmu17 - Retrospective Study of Patients Using Elbasvir/Grazoprevir in France

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Elbasvir/Grazoprevir and Sofosbuvir for HCV Genotype 3 Infection With Compensated Cirrhosis: A Randomized Trial

Hepatology
MedicineHepatology
2018English

An Integrated Analysis of Elbasvir/Grazoprevir in Korean Patients With Hepatitis C Virus Genotype 1b Infection

Clinical and molecular hepatology
MedicineHepatologyMolecular Biology
2019English

Elbasvir/Grazoprevir for Patients With Hepatitis C Virus Infection and Inherited Blood Disorders: A Phase III Study

Hepatology
MedicineHepatology
2017English

Real-Life Experiences of Patients With Parkinson's Disease

Kontakt
EnvironmentalPublic HealthPhilosophyNursingOccupational Health
2019English

Pharmacokinetic Interactions Between the HCV Inhibitors Elbasvir and Grazoprevir and HIV Protease Inhibitors Ritonavir, Atazanavir, Lopinavir, or Darunavir in Healthy Participants

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

Effectiveness of Elbasvir/Grazoprevir in US Veterans With Chronic Hepatitis C Virus Genotype 1b Infection

Infectious Diseases and Therapy
Infectious DiseasesMicrobiology
2020English

Efficacy and Safety of Hepatitis C Direct-Acting Protease Inhibitors (DAA-PI ) in Real Life in HIV-HCV Coinfected Patients

BMC Infectious Diseases
Infectious Diseases
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy